- Preview Available
- Scholarly Journal
Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial
Signal Transduction and Targeted Therapy; London Vol. 9, Iss. 1, (2024): 359.
DOI:10.1038/s41392-024-02085-8
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.